AstraZeneca Pharma India shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters75.00%no change
Foreign investors (FII)2.64%−0.04 pts
Domestic institutions (DII)7.09%+1.01 pts
of which mutual funds7.01%+1.00 pts
Public15.27%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ASTRAZEN₹6,237.00

AstraZeneca Pharma India Limited

· Pharma & Health
₹ CrorePeersSANOFICONRPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCMcap ₹15,593 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group75.0075.0075.0075.0075.0075.0075.0075.0075.0075.00
FII / FPI2.792.902.932.893.032.742.712.782.682.64
DII5.015.105.224.654.565.265.565.806.087.09
Mutual Funds4.975.055.044.454.335.005.435.666.017.01
Latest: 2026-09-30 · 21 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.